Income Statement Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 09:25:00 11/05/2026 pm IST			Pre-market 12:16:52 pm
58.52 ^EUR	-1.38%		58.00	-0.89%

11/05	CAC 40: Luxury and Geopolitics Weigh on Sentiment
11/05	Eurofins among top CAC 40 decliners as BofA downgrades

2f88d27c1aa909.zYj6azOJpHOtw6tU2QW7AyTKtrySQjs4WbT9He2GQzY.-NKjLkbnyDv8q_k_v3LcTFOA0P_CF3cVYOufKYK2EwSj8bQlRv-cKfr38g

Published financial data: EUROFINS SCIENTIFIC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	671.77Cr	671.21Cr	651.46Cr	695.1Cr	729.61Cr
Total Revenues	671.77Cr	671.21Cr	651.46Cr	695.1Cr	729.61Cr
Cost of Goods Sold, Total	480.39Cr	518.58Cr	513.99Cr	539.08Cr	565.52Cr
Gross Profit	191.38Cr	152.63Cr	137.47Cr	156.02Cr	164.09Cr
Selling General & Admin Expenses, Total	1.28Cr	1.42Cr	1.31Cr	1.05Cr	21L
Stock-Based Compensation (IS)	12Cr	13Cr	12Cr	12Cr	11Cr
Depreciation & Amortization - (IS)	43Cr	48Cr	52Cr	54Cr	56Cr
Other Operating Expenses, Total	56Cr	62Cr	66Cr	66Cr	68Cr
Operating Income	135.23Cr	91Cr	72Cr	90Cr	96Cr
Interest Expense, Total	-9.43Cr	-9.16Cr	-12Cr	-15Cr	-15Cr
Net Interest Expenses	-9.43Cr	-9.16Cr	-12Cr	-15Cr	-15Cr
Income (Loss) On Equity Invest.	20L	9L	4L	10L	3L
Currency Exchange Gains (Loss)	-1.79Cr	-3.29Cr	1.12Cr	49L	2.46Cr
Other Non Operating Income (Expenses)	18L	-1.16Cr	72L	1.71Cr	7L
EBT, Excl. Unusual Items	124.39Cr	77Cr	61Cr	77Cr	84Cr
Restructuring Charges	-3.22Cr	-	-	-	-6.81Cr
Merger & Related Restructuring Charges	-1.36Cr	-87L	-1.51Cr	-2.41Cr	-2.55Cr
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	14Cr	-18L	-2.36Cr	-89L
Other Unusual Items	-14Cr	-13Cr	-17Cr	-17Cr	-7.88Cr
EBT, Incl. Unusual Items	105.66Cr	78Cr	42Cr	55Cr	65Cr
Income Tax Expense	27Cr	17Cr	12Cr	15Cr	18Cr
Earnings From Continuing Operations	78Cr	61Cr	31Cr	41Cr	47Cr
Net Income to Company	78Cr	61Cr	31Cr	41Cr	47Cr
Minority Interest	-4L	44L	25L	9L	18L
Net Income - (IS)	78Cr	61Cr	31Cr	41Cr	47Cr
Preferred Dividend and Other Adjustments	3.41Cr	2.93Cr	5.37Cr	5.01Cr	5.87Cr
Net Income to Common Incl Extra Items	75Cr	58Cr	26Cr	36Cr	42Cr
Net Income to Common Excl. Extra Items	75Cr	58Cr	26Cr	36Cr	42Cr
Per Share Items
Net EPS - Basic	3.91	3.02	1.33	1.87	2.31
Basic EPS - Continuing Operations	3.91	3.02	1.33	1.87	2.31
Basic Weighted Average Shares Outstanding	19Cr	19Cr	19Cr	19Cr	18Cr
Net EPS - Diluted	3.73	2.92	1.3	1.83	2.23
Diluted EPS - Continuing Operations	3.73	2.92	1.3	1.83	2.23
Diluted Weighted Average Shares Outstanding	20Cr	20Cr	20Cr	19Cr	19Cr
Normalized Basic EPS	4.06	2.53	2	2.54	2.91
Normalized Diluted EPS	3.87	2.45	1.95	2.49	2.81
Dividend Per Share	1	1	0.5	0.6	0.72
Payout Ratio	21.22	37.36	75.4	36.69	33.15
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	174.79Cr	135.25Cr	118.71Cr	136.69Cr	145.52Cr
EBITA	144.99Cr	101.32Cr	82Cr	99Cr	105.71Cr
EBIT	135.23Cr	91Cr	72Cr	90Cr	96Cr
EBITDAR	176Cr	136.59Cr	119.81Cr	137.49Cr	-
Effective Tax Rate - (Ratio)	25.89	22.33	27.29	26.88	27.69
Total Current Taxes	30Cr	20Cr	16Cr	19Cr	16Cr
Total Deferred Taxes	-2.63Cr	-2.7Cr	-4.14Cr	-3.59Cr	1.66Cr
Normalized Net Income	78Cr	49Cr	39Cr	48Cr	52Cr
Interest on Long-Term Debt	7.27Cr	7.63Cr	11Cr	12Cr	12Cr
Non-Cash Pension Expense	5L	4L	22L	21L	21L
Supplemental Operating Expense Items
Net Rental Expense, Total	1.21Cr	1.34Cr	1.1Cr	80L	-
Imputed Operating Lease Interest Expense	30.9L	32.3L	29.95L	24.88L	-
Imputed Operating Lease Depreciation	90.1L	1.02Cr	80.05L	55.12L	-
Stock-Based Comp., Other (Total)	12Cr	13Cr	12Cr	12Cr	11Cr
Total Stock-Based Compensation	12Cr	13Cr	12Cr	12Cr	11Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	52Cr	49Cr	122.12Cr	61Cr	79Cr
Trading Asset Securities, Total	5L	56L	43L	20L	30L
Total Cash And Short Term Investments	52Cr	49Cr	122.55Cr	62Cr	79Cr
Accounts Receivable, Total	138.92Cr	134.17Cr	138.05Cr	140.05Cr	142.13Cr
Other Receivables	19Cr	26Cr	24Cr	21Cr	22Cr
Total Receivables	158.1Cr	159.73Cr	161.7Cr	160.88Cr	164.39Cr
Inventory	15Cr	15Cr	14Cr	14Cr	14Cr
Prepaid Expenses	6.8Cr	7.83Cr	8.49Cr	8.57Cr	7.61Cr
Other Current Assets, Total	-	-1L	-	-1L	-
Total Current Assets	231.9Cr	231.33Cr	306.64Cr	245.22Cr	265.35Cr
Gross Property Plant And Equipment	402.08Cr	473.68Cr	491.91Cr	543.51Cr	577.81Cr
Accumulated Depreciation	-219.09Cr	-256.91Cr	-262.17Cr	-287.53Cr	-301.52Cr
Net Property Plant And Equipment	182.99Cr	216.77Cr	229.74Cr	255.98Cr	276.29Cr
Long-term Investments	8.17Cr	8.36Cr	8.36Cr	12Cr	11Cr
Goodwill	411.51Cr	452.41Cr	455.14Cr	484.07Cr	465.72Cr
Other Intangibles, Total	90Cr	92Cr	80Cr	79Cr	69Cr
Deferred Tax Assets Long-Term	9.09Cr	7.57Cr	9.38Cr	13Cr	12Cr
Other Long-Term Assets, Total	-	-	-	2L	-
Total Assets	933.23Cr	1.01TCr	1.09TCr	1.09TCr	1.1TCr
Liabilities
Accounts Payable, Total	32Cr	35Cr	34Cr	38Cr	40Cr
Accrued Expenses, Total	86Cr	84Cr	82Cr	87Cr	91Cr
Short-term Borrowings	8.03Cr	7.85Cr	3L	8.31Cr	25Cr
Current Portion of Long-Term Debt	5.28Cr	67L	46Cr	25Cr	34Cr
Current Portion of Leases	12Cr	13Cr	14Cr	15Cr	14Cr
Current Income Taxes Payable	8.6Cr	3.47Cr	2.67Cr	3.55Cr	2.98Cr
Unearned Revenue Current, Total	16Cr	18Cr	19Cr	20Cr	22Cr
Other Current Liabilities	17Cr	16Cr	14Cr	16Cr	15Cr
Total Current Liabilities	185.58Cr	177.22Cr	212.17Cr	211.02Cr	242.96Cr
Long-Term Debt	208.21Cr	271.28Cr	288.94Cr	267.42Cr	340.73Cr
Long-Term Leases	42Cr	40Cr	44Cr	46Cr	30Cr
Pension & Other Post Retirement Benefits	7.55Cr	5.95Cr	6.62Cr	6.64Cr	6.42Cr
Deferred Tax Liability Non Current	12Cr	13Cr	11Cr	11Cr	12Cr
Other Non Current Liabilities	10Cr	16Cr	13Cr	8.6Cr	8.85Cr
Total Liabilities	465.52Cr	523.25Cr	575.12Cr	550.36Cr	640.87Cr
Common Stock, Total	19L	19L	19L	19L	18L
Retained Earnings	196.44Cr	233.3Cr	239.38Cr	269.22Cr	302.37Cr
Treasury Stock	-36L	-1.42Cr	-5.49Cr	-31Cr	-30Cr
Comprehensive Income and Other	268.49Cr	246.14Cr	273.67Cr	295.27Cr	181.67Cr
Total Common Equity	464.76Cr	478.21Cr	507.75Cr	533.9Cr	454.33Cr
Minority Interest	2.95Cr	6.89Cr	5.99Cr	4.58Cr	3.34Cr
Total Equity	467.71Cr	485.1Cr	513.74Cr	538.48Cr	457.67Cr
Total Liabilities And Equity	933.23Cr	1.01TCr	1.09TCr	1.09TCr	1.1TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	19Cr	19Cr	19Cr	19Cr	18Cr
ECS Total Common Shares Outstanding	19Cr	19Cr	19Cr	19Cr	18Cr
Book Value / Share	18.98	21.8	21.14	23.23	20.05
Tangible Book Value	-36Cr	-66Cr	-27Cr	-29Cr	-80Cr
Tangible Book Value Per Share	-7.09	-6.46	-6.58	-6.9	-10.21
Total Debt	275.41Cr	332.56Cr	392.67Cr	361.03Cr	443.2Cr
Net Debt	223.83Cr	283.34Cr	270.12Cr	299.44Cr	363.78Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	7.56Cr	5.95Cr	6.63Cr	6.64Cr	6.42Cr
Debt Equivalent Oper. Leases	9.68Cr	11Cr	8.8Cr	6.4Cr	-
Minority Interest, Total (Incl. Fin. Div)	2.95Cr	6.89Cr	5.99Cr	4.58Cr	3.34Cr
Equity Method Investments, Total	62L	52L	53L	59L	53L
Account Code - Inventory Valuation	5	5	5	-	5
Inventories - Others	19Cr	17Cr	16Cr	16Cr	15Cr
Land - (BS)	99Cr	128.24Cr	145.48Cr	-	219.26Cr
Machinery, Total	194.31Cr	226.94Cr	237.53Cr	434.56Cr	263.47Cr
Full Time Employees	57.99T	61.38T	61.8T	62.7T	65.69T
Accumulated Allowance for Doubtful Accounts (Supple)	5.51Cr	5.79Cr	6.33Cr	6.05Cr	5.89Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	78Cr	61Cr	31Cr	41Cr	47Cr
Depreciation & Amortization - CF	43Cr	48Cr	52Cr	54Cr	56Cr
Amortization of Goodwill and Intangible Assets - (CF)	9.76Cr	10Cr	9.93Cr	9.47Cr	9.34Cr
Depreciation & Amortization, Total	53Cr	58Cr	62Cr	63Cr	65Cr
Amortization of Deferred Charges, Total - (CF)	73L	38L	47L	48L	46L
(Gain) Loss From Sale Of Asset	1L	-14Cr	18L	2.36Cr	89L
Asset Writedown & Restructuring Costs	2.19Cr	4.17Cr	7.28Cr	7.6Cr	7.74Cr
(Income) Loss On Equity Investments - (CF)	-20L	-9L	-4L	-10L	-3L
Stock-Based Compensation (CF)	2.22Cr	2.29Cr	2.33Cr	2.18Cr	1.98Cr
Other Operating Activities, Total	16Cr	-1.17Cr	4.9Cr	11Cr	11Cr
Change In Accounts Receivable	-20Cr	4.75Cr	-4.34Cr	3.72Cr	-4.45Cr
Change In Inventories	28L	86L	1.1Cr	36L	14L
Change In Accounts Payable	8.56Cr	2.01Cr	-4.13Cr	-2.59Cr	2.5Cr
Change in Unearned Revenues	2.63Cr	2.11Cr	1.02Cr	-30L	2.63Cr
Change In Deferred Taxes	-63L	-75L	-	-	-
Change in Other Net Operating Assets	8.2Cr	-5.86Cr	-13L	3.2Cr	4.29Cr
Cash from Operations	150.98Cr	113.63Cr	101.79Cr	131.89Cr	139.89Cr
Capital Expenditure	-46Cr	-58Cr	-48Cr	-45Cr	-76Cr
Sale of Property, Plant, and Equipment	2.48Cr	1.49Cr	64L	1.02Cr	1.42Cr
Cash Acquisitions	-53Cr	-43Cr	-16Cr	-34Cr	-26Cr
Divestitures	-	22Cr	73L	-9L	-28L
Sale (Purchase) of Intangible assets	-6.2Cr	-8.41Cr	-7.2Cr	-7.48Cr	-7.49Cr
Investment in Marketable and Equity Securities, Total	-84L	15L	19L	-33L	-20L
Other Investing Activities, Total	16L	26L	1.15Cr	1.93Cr	1.06Cr
Cash from Investing	-103.42Cr	-86Cr	-68Cr	-85Cr	-107.62Cr
Long-Term Debt Issued, Total	83Cr	63Cr	64Cr	12Cr	122.18Cr
Total Debt Issued	83Cr	63Cr	64Cr	12Cr	122.18Cr
Long-Term Debt Repaid, Total	-143.34Cr	-25Cr	-27Cr	-67Cr	-50Cr
Total Debt Repaid	-143.34Cr	-25Cr	-27Cr	-67Cr	-50Cr
Issuance of Common Stock	3.58Cr	1.46Cr	60Cr	2L	40Cr
Repurchase of Common Stock	-36L	-43Cr	-24Cr	-27Cr	-94Cr
Common Dividends Paid	-17Cr	-23Cr	-23Cr	-15Cr	-16Cr
Common & Preferred Stock Dividends Paid	-17Cr	-23Cr	-23Cr	-15Cr	-16Cr
Other Financing Activities, Total	-17Cr	-4.97Cr	-8.35Cr	-12Cr	-12Cr
Cash from Financing	-91Cr	-31Cr	41Cr	-108.95Cr	-10Cr
Foreign Exchange Rate Adjustments	3.91Cr	-8L	-1.27Cr	94L	-4.66Cr
Miscellaneous Cash Flow Adjustments	1L	-1L	1L	-	1L
Net Change in Cash	-40Cr	-3.18Cr	74Cr	-61Cr	17Cr
Supplemental Items
Cash Interest Paid	17Cr	4.94Cr	8.22Cr	11Cr	12Cr
Cash Income Tax Paid (Refund)	30Cr	30Cr	14Cr	16Cr	19Cr
Levered Free Cash Flow	87Cr	50Cr	51Cr	81Cr	49Cr
Unlevered Free Cash Flow	92Cr	55Cr	58Cr	90Cr	58Cr
Change In Net Working Capital	5.43Cr	6.14Cr	5.76Cr	-12Cr	-4.85Cr
Net Debt Issued / Repaid	-61Cr	38Cr	37Cr	-55Cr	72Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.44	5.85	4.27	5.15	5.51
Return on Total Capital	11.82	7.28	5.2	6.21	6.69
Return On Equity %	18.66	12.72	6.16	7.71	9.5
Return on Common Equity	17.95	12.32	5.2	6.84	8.42
Margin Analysis
Gross Profit Margin %	28.49	22.74	21.1	22.45	22.49
SG&A Margin	0.19	0.21	0.2	0.15	0.03
EBITDA Margin %	26.02	20.15	18.22	19.66	19.94
EBITA Margin %	21.58	15.1	12.53	14.28	14.49
EBIT Margin %	20.13	13.54	11.01	12.92	13.21
Income From Continuing Operations Margin %	11.66	9.03	4.72	5.83	6.48
Net Income Margin %	11.65	9.09	4.76	5.85	6.51
Net Avail. For Common Margin %	11.14	8.65	3.94	5.13	5.7
Normalized Net Income Margin	11.57	7.27	5.91	6.98	7.18
Levered Free Cash Flow Margin	12.89	7.46	7.86	11.66	6.75
Unlevered Free Cash Flow Margin	13.66	8.26	8.97	12.91	8.01
Asset Turnover
Asset Turnover	0.75	0.69	0.62	0.64	0.67
Fixed Assets Turnover	3.95	3.36	2.92	2.86	2.74
Receivables Turnover (Average Receivables)	5.2	4.92	4.79	5	5.17
Inventory Turnover (Average Inventory)	30.87	34.6	36.12	38.38	40.22
Short Term Liquidity
Current Ratio	1.25	1.31	1.45	1.16	1.09
Quick Ratio	1.13	1.18	1.34	1.05	1
Operating Cash Flow to Current Liabilities	0.81	0.64	0.48	0.63	0.58
Days Sales Outstanding (Average Receivables)	70.16	74.25	76.26	73.22	70.58
Days Outstanding Inventory (Average Inventory)	11.82	10.55	10.11	9.54	9.07
Average Days Payable Outstanding	22.87	23.63	24.41	24.26	25.01
Cash Conversion Cycle (Average Days)	59.11	61.17	61.95	58.49	54.65
Long Term Solvency
Total Debt/Equity	58.88	68.55	76.43	67.05	96.84
Total Debt / Total Capital	37.06	40.67	43.32	40.14	49.2
LT Debt/Equity	53.46	64.15	64.73	58.15	80.96
Long-Term Debt / Total Capital	33.65	38.06	36.69	34.81	41.13
Total Liabilities / Total Assets	49.88	51.89	52.82	50.55	58.34
EBIT / Interest Expense	14.34	9.92	5.81	6.13	6.26
EBITDA / Interest Expense	19.92	16.26	10.85	10.45	10.52
(EBITDA - Capex) / Interest Expense	15.07	9.97	6.97	7.35	5.58
Total Debt / EBITDA	1.47	2.23	2.93	2.36	2.74
Net Debt / EBITDA	1.19	1.9	2.02	1.96	2.25
Total Debt / (EBITDA - Capex)	1.94	3.64	4.56	3.35	5.16
Net Debt / (EBITDA - Capex)	1.57	3.1	3.14	2.78	4.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.51	-0.08	-2.94	6.7	4.96
Gross Profit, 1 Yr. Growth %	35.47	-19.74	-9.13	14.41	5.71
EBITDA, 1 Yr. Growth %	37.19	-22.63	-12.23	15.15	6.46
EBITA, 1 Yr. Growth %	43.95	-30.12	-19.43	21.59	6.51
EBIT, 1 Yr. Growth %	49.52	-33.09	-21.1	25.22	7.34
Earnings From Cont. Operations, 1 Yr. Growth %	44.89	-22.63	-49.21	31.78	16.65
Net Income, 1 Yr. Growth %	45.09	-22.03	-49.16	31.01	16.83
Normalized Net Income, 1 Yr. Growth %	55.93	-37.51	-21.03	25.85	8.06
Diluted EPS Before Extra, 1 Yr. Growth %	44.57	-21.72	-55.48	40.77	21.86
Accounts Receivable, 1 Yr. Growth %	16.4	-3.42	2.89	1.45	1.49
Inventory, 1 Yr. Growth %	-1.78	-5.58	-4.53	2.09	-1.83
Net Property, Plant and Equip., 1 Yr. Growth %	16.19	18.46	5.98	11.42	7.93
Total Assets, 1 Yr. Growth %	8.83	8.05	7.98	-0	0.89
Tangible Book Value, 1 Yr. Growth %	-44.88	82.02	-59.17	7.26	177.65
Common Equity, 1 Yr. Growth %	25.94	2.89	6.18	5.15	-14.9
Cash From Operations, 1 Yr. Growth %	23.4	-24.82	-10.42	29.57	6.07
Capital Expenditures, 1 Yr. Growth %	47.2	29.64	-17.01	-5.12	67.53
Levered Free Cash Flow, 1 Yr. Growth %	9.2	-42.8	2.22	58.34	-39.24
Unlevered Free Cash Flow, 1 Yr. Growth %	7.54	-39.94	5.43	53.57	-34.91
Dividend Per Share, 1 Yr. Growth %	47.06	0	-50	20	20
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.34	11.09	-1.52	1.76	5.83
Gross Profit, 2 Yr. CAGR %	43.39	3.94	-14.98	1.55	9.69
EBITDA, 2 Yr. CAGR %	48.28	3.03	-17.59	0.53	10.72
EBITA, 2 Yr. CAGR %	61.43	0.3	-24.97	-1.03	13.8
EBIT, 2 Yr. CAGR %	72.13	0.24	-27.34	-0.6	15.93
Earnings From Cont. Operations, 2 Yr. CAGR %	100.28	5.88	-37.31	-18.19	23.98
Net Income, 2 Yr. CAGR %	100.23	6.36	-37.04	-18.39	23.72
Normalized Net Income, 2 Yr. CAGR %	85.25	-1.06	-29.75	-0.31	16.62
Diluted EPS Before Extra, 2 Yr. CAGR %	118.68	6.39	-40.96	-20.83	30.97
Accounts Receivable, 2 Yr. CAGR %	17.79	6.03	-0.31	2.17	1.47
Inventory, 2 Yr. CAGR %	39.45	-3.7	-5.06	-1.28	0.11
Net Property, Plant and Equip., 2 Yr. CAGR %	7.16	17.32	12.05	8.67	9.66
Total Assets, 2 Yr. CAGR %	9.22	8.44	8.02	3.91	0.44
Tangible Book Value, 2 Yr. CAGR %	-53.62	0.17	-13.8	-33.83	72.57
Common Equity, 2 Yr. CAGR %	27.96	13.84	4.52	5.66	-5.41
Cash From Operations, 2 Yr. CAGR %	49.24	-3.63	-17.93	7.74	17.23
Capital Expenditures, 2 Yr. CAGR %	28.24	36.15	3.72	-11.27	26.07
Levered Free Cash Flow, 2 Yr. CAGR %	40.93	-20.54	-23.53	27.22	-1.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	36.29	-19.41	-20.43	27.24	-0.02
Dividend Per Share, 2 Yr. CAGR %	70.25	21.27	-29.29	-22.54	20
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	21.12	13.73	6.2	1.14	2.82
Gross Profit, 3 Yr. CAGR %	38.54	17.92	-0.9	-6.38	2.74
EBITDA, 3 Yr. CAGR %	35.18	19.38	-2.33	-7.87	2.47
EBITA, 3 Yr. CAGR %	41.79	22.12	-6.77	-11.87	1.42
EBIT, 3 Yr. CAGR %	46.42	25.8	-7.45	-12.89	1.98
Earnings From Cont. Operations, 3 Yr. CAGR %	51.88	45.86	-17.12	-19.7	-7.92
Net Income, 3 Yr. CAGR %	51.76	46.22	-16.84	-19.62	-8.02
Normalized Net Income, 3 Yr. CAGR %	48.71	29.15	-8.22	-14.68	2.41
Diluted EPS Before Extra, 3 Yr. CAGR %	57.32	55.27	-20.43	-21.13	-8.59
Accounts Receivable, 3 Yr. CAGR %	17.11	10.25	4.97	0.27	1.94
Inventory, 3 Yr. CAGR %	32.43	22.45	-3.98	-2.73	-1.46
Net Property, Plant and Equip., 3 Yr. CAGR %	21.59	10.8	13.41	11.84	8.42
Total Assets, 3 Yr. CAGR %	9	8.83	8.29	5.28	2.9
Tangible Book Value, 3 Yr. CAGR %	-40.17	-26.84	-25.73	-7.28	6.73
Common Equity, 3 Yr. CAGR %	20.3	18.99	11.22	4.73	-1.69
Cash From Operations, 3 Yr. CAGR %	40.54	18.79	-5.95	-4.44	7.18
Capital Expenditures, 3 Yr. CAGR %	12.4	27.46	15.44	0.69	9.67
Levered Free Cash Flow, 3 Yr. CAGR %	61.96	4.72	-13.58	-2.54	-0.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	56.07	3.91	-11.86	-0.93	1.77
Dividend Per Share, 3 Yr. CAGR %	51.43	42.58	-9.74	-15.66	-10.37
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	21.5	17.7	11.49	8.78	6.05
Gross Profit, 5 Yr. CAGR %	31.89	22.35	13.82	10.88	3.04
EBITDA, 5 Yr. CAGR %	29.91	19.75	10.9	11.45	2.69
EBITA, 5 Yr. CAGR %	32.85	20.92	9.92	12.27	0.97
EBIT, 5 Yr. CAGR %	33.47	20.94	10.73	14.49	1.28
Earnings From Cont. Operations, 5 Yr. CAGR %	34.56	22.59	6.6	15.74	-2.63
Net Income, 5 Yr. CAGR %	35.08	23	6.74	15.8	-2.52
Normalized Net Income, 5 Yr. CAGR %	35.19	20.91	10.27	16.45	1.01
Diluted EPS Before Extra, 5 Yr. CAGR %	35.52	23.98	6.3	18.6	-2.87
Accounts Receivable, 5 Yr. CAGR %	21.51	13.71	9.8	6.94	3.56
Inventory, 5 Yr. CAGR %	31.28	22.96	15.92	12.34	-2.36
Net Property, Plant and Equip., 5 Yr. CAGR %	29.28	25.87	17.68	9.94	11.9
Total Assets, 5 Yr. CAGR %	17.71	11.57	8.61	6.84	5.08
Tangible Book Value, 5 Yr. CAGR %	1.31	-3.68	-30.76	-29.72	4.06
Common Equity, 5 Yr. CAGR %	23.35	14.38	13.72	13.47	4.25
Cash From Operations, 5 Yr. CAGR %	32.35	22.91	13.35	14.24	2.72
Capital Expenditures, 5 Yr. CAGR %	24.05	23.48	8.21	10.27	19.58
Levered Free Cash Flow, 5 Yr. CAGR %	45.41	24.54	20.22	13.2	-9.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	39.43	22.92	19.34	12.68	-7.3
Dividend Per Share, 5 Yr. CAGR %	37.97	33.03	11.66	11.7	1.15